Sarah H Kim, MD, MSCE

« More

Selected recent publications

Lectures by Invitation (Last 5 years):

Aug, 2007 "New Advances in Ovarian Cancer Therapy and Research"
Moms on the Move, Channel NBC10
Sep, 2007 "Challenges and Opportunities in Ovarian Cancer Therapy"
Teal Talk over Tea, National Ovarian Cancer Coalition
Fairmount Water Works, Philadelphia, PA
Mar, 2008 Guest Lecturer, Annual Resident Research Presentation
Cooper University Hospital, UMDNJ
Apr, 2008 Eighth Annual Focus on Gynecologic Cancers Conference, Hilton Hotel, Philadelphia, PA

Bibliography:

Research Publications, peer reviewed (print or other media):

1. Maguire H, Berd D, Lattime E, McCue P, Kim S, Chapman P, Mastrangelo M: Phase I Study of R24 in Patients with Metastatic Melanoma Including Evaluation of Immunological Parameters. Cancer Biother & Radiopharm 13(1):13-23, 1998.
   
   2. Slovin SF, Ragupathi G, Adluri S, Ungers G, Terry K, Kim S, Livingston PO, Scher HI: Carbohydrate Vaccines in Cancer: Immunogenicity of a Fully Synthetic Globo H Hexasaccharide Conjugate in Man. Proc Natl Acad Sci 96:5710-5715, 1999.
   
   3. Kim S, Srinivas S, Rubin S, Freedman L, Gray H: Delayed Hemorrhage after Cervical Conization Unmasking Severe Factor XI Deficiency. Obstet Gynecol 104(5):1189-1192, 2004.
   
   4. Buckanovich RJ, Facciabene A, Kim S, Benecia F, Sasaroli D, Balint K, Katsaros D, O'Brien-Jenkins A, Gimotty PA, Coukos G: Endothelin (B) Receptor Mediates the Endothelial Barrier to T-Cell Homing to Tumors, and its Neutralization Enables Tumor Immune Therapy. Nat Med 14(1):28-36, 2008.
   
   5. Chu CS, Kim S, June CH, Coukos G: Immunotherapy Opportunities in Ovarian Cancer. Expert Rev Anticancer Ther 8(2):1-5, 2008.
   
   6. Yang N, Huang J, Greshock J, Liang S, Barchetti A, Hasegawa K, Kim S, Giannakakis A, Li S, O'Brien-Jenkins A, Katsaros D, Butzow R, Coukos G, Zhang L: Transcriptional Regulation of PIK3CA Oncogene by NF-xB in Ovarian Cancer Microenvironment. PLoS One 12(3):e1758, 2008.
   
   7. Gimotty P, Zhang L, Alagkiozidis I, Kim S, Cadungog M, Adams S, Chu CS, Katsaros D, Coukos G: Immune Porgnostic Factors in Ovarian Cancer: Lessons from Translational Research. Dis Markers, 23(5-6):445-52.
   
   8. Kim S, Liao J, Chu CS, Coukos G: Tumor microenvironment: Biomarker for use of immunoassessment cancer vaccines? under review.
   
   9. Kim S, Morgan M, Coukos G, Rubin S, Chu C: Analysis of Survival Outcomes of Stage I Clear Cell Carcinoma of the Ovary, under review.

Research Publications

1. Kim S, Hageman A, DeMichele A. Immuno-Modulatory Gene Polymorphisms and Outcome in Breast and Ovarian Cancers, Immunol Invest, in press.

Abstracts (Last 3 years):

1. 1. Buckanovich R, Kim S, Benecia F, Sasaroli D, Gimotty P, Coukos G: Antagonism of endothelin receptor B increases intratumoral T-cell trafficking and effectively enhances antitumor vaccine therapy of ovarian cancer. Poster presentation at the Society of Gynecologic Oncologists 37th Annual Meeting, March, 2006.
2. Kim S, Buckanovich R, Katsaros D, Gimotty P, Coukos G: Endothelin receptor B as a biomarker of suboptimal cytoreduction and poor clinical outcome in epithelial ovarian carcinoma. Poster presentation at the Society of Gynecologic Oncologists 37th Annual Meeting, March, 2006.
3. Kim S, Lee K, Chu C: HER2/neu expression in primary and recurrent epithelial ovarian cancer. Poster presentation at the Western Association of Gynecologic Oncologists 35th Annual Meeting, May, 2006.
4. Kim S, Gleason J, Buckanovich R, Sasaroli D, Chu C, Katsaros D, Gimotty P, Dumoff K, Coukos G: Neuropillin-2 as biomarker of poor clinical outcomes in epithelial ovarian cancers. Poster presentation at the Society of Gynecologic Oncologists 39th Annual Meeting, March, 2008.
5. Kim S, Lee K, Gleason J, Adams S, Cadungog M, Chu C, Katsaros D, Gimotty P, Dumoff K, Coukos G: Presence of intratumoral T cells in recurrent ovarian cancer predicts favorable clinical outcomes. Poster presentation at the Society of Gynecologic Oncologists 39th Annual Meeting, March, 2008.
6. Kim S, McCann G, Chu CS. Adjuvant sandwich regimen of chemotherapy and radiation for advanced endometrial cancer. Oral presentation at the Mid-Atlantic Gynecologic Oncology Society 23rd Annual Meeting, September 2008.
   

Video

Introductory Video of Dr.Kim

Surgical Oncology
Division of Gynecologic Oncology
Attending Surgeon,
Assistant Professor

Meet other members of the gynecological cancer treatment team.

New patients can request an appointment online or call 215-728-2570.

Appointments for Returning Patients

For general information, call:
1-888-FOX CHASE (1-888-369-2427).
An oncology certified nurse will assist you.

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111-2497

Clinical Expertise:

Ovarian Cancer, Endometrial Cancer, Uterine Sarcoma,Vulvar Cancer and Cervical Cancer; Gestational Trophoblastic Disease; Laparoscopic Surgery; Complex Gynecologic Surgery

Medical Education:

Masters of Science in Clinical Epidemiology., University of Pennsylvania School of Medicine, Philadelphia, PA, 2009;
MD, Upstate Medical University, SUNY College of Medicine, 2000

Residency:

Resident in Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2004

Fellowships:

Gynecologic Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2007

Certification:

American Board of Obstetrics and Gynecology

Professional Societies:

American College of Obstetricians and Gynecologists;
American Medical Association;
American Society of Clinical Oncology;
Society of Gynecologic Oncologists

Research Interests:

Utilizing my degree in Master of Science in Clinical Epidemiology, I hope to develop novel and innovative clinical trials in gynecologic oncology and collaborate with Fox Chase scientists in advancement of translational research. I hope to continue bringing the fight for women cancers even more to the forefront of public awareness.
- Clinical trials
- Biomarkers to pre-biomarkers to predict response to targeted therapies